Literature DB >> 20676841

Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome.

Kunihisa Miwa1, Masatoshi Fujita.   

Abstract

The etiology of chronic fatigue syndrome remains unknown. Oxidative stress may be involved in its pathogenesis. Vitamin E is a major endogenous lipid-soluble antioxidative substance, and is consumed during the lipid peroxidation process. We studied a population comprising 27 patients with chronic fatigue syndrome (10 men and 17 women, 29 +/- 6 years of age) and 27 age- and sex-matched control subjects. Serum vitamin E (alpha-tocopherol) concentrations were determined and expressed as mg/g total lipids (total cholesterol and triglyceride) to evaluate oxidative stress. Serum alpha-tocopherol concentrations (mg/g lipids) were significantly (P < 0.001) lower in the patients with chronic fatigue syndrome (2.81 +/- 0.73) than in the control subjects (3.88 +/- 0.65). The patients with chronic fatigue syndrome were re-examined during a follow-up interval. After 8 +/- 2 months, 16 patients exhibited a status that warranted re-examination during remission of the symptoms at a regular visit to our hospital (Group 1), while the remaining 11 did not (Group 2). The serum alpha-tocopherol levels were significantly elevated during remission as compared with those at baseline in Group 1 (2.71 +/- 0.62 --> 3.24 +/- 0.83, P < 0.001). The levels did not significantly change after the interval in Group 2 (2.97 +/- 0.86 --> 2.85 +/- 0.73, not significant). In conclusion, serum alpha-tocopherol concentrations were significantly lower in the patients with chronic fatigue syndrome as compared with the control subjects, suggesting increased oxidative stress in the former. The low level of serum alpha-tocopherol was ameliorated during the remission phase as compared with the exacerbation phase in the patients with chronic fatigue syndrome, suggesting that increased oxidative stress may be involved in the pathogenesis of chronic fatigue syndrome and might also be directly related to the severity of the symptoms of chronic fatigue syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20676841     DOI: 10.1007/s00380-009-1206-6

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  31 in total

1.  Gender difference in oxidative stress and its genesis by analysis of serum alpha-tocopherol concentrations in a Japanese population.

Authors:  Kunihisa Miwa; Masatoshi Fujita
Journal:  Int J Cardiol       Date:  2007-07-25       Impact factor: 4.164

2.  Small heart syndrome in patients with chronic fatigue syndrome.

Authors:  Kunihisa Miwa; Masatoshi Fujita
Journal:  Clin Cardiol       Date:  2008-07       Impact factor: 2.882

3.  Increased oxidative stress suggested by low serum vitamin E concentrations in patients with chronic fatigue syndrome.

Authors:  Kunihisa Miwa; Masatoshi Fujita
Journal:  Int J Cardiol       Date:  2008-08-06       Impact factor: 4.164

4.  Superoxide production in rat hippocampal neurons: selective imaging with hydroethidine.

Authors:  V P Bindokas; J Jordán; C C Lee; R J Miller
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Electrophysiological correlates of peroxide damage in guinea pig hippocampus in vitro.

Authors:  T Pellmar
Journal:  Brain Res       Date:  1986-02-05       Impact factor: 3.252

7.  The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group.

Authors:  K Fukuda; S E Straus; I Hickie; M C Sharpe; J G Dobbins; A Komaroff
Journal:  Ann Intern Med       Date:  1994-12-15       Impact factor: 25.391

8.  Serum thioredoxin and alpha-tocopherol concentrations in patients with major risk factors.

Authors:  Kunihisa Miwa; Chiharu Kishimoto; Hajime Nakamura; Toshinori Makita; Katsuhisa Ishii; Nobuaki Okuda; Junji Yodoi; Shigetake Sasayama
Journal:  Circ J       Date:  2005-03       Impact factor: 2.993

9.  Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome.

Authors:  Jacopo Vecchiet; Francesco Cipollone; Katia Falasca; Andrea Mezzetti; Eligio Pizzigallo; Tonino Bucciarelli; Silvana De Laurentis; Giannapia Affaitati; Domenico De Cesare; Maria Adele Giamberardino
Journal:  Neurosci Lett       Date:  2003-01-02       Impact factor: 3.046

10.  Low serum alpha-tocopherol concentrations in subjects with various coronary risk factors.

Authors:  Kunihisa Miwa; Satoshi Okinaga; Masatoshi Fujita
Journal:  Circ J       Date:  2004-06       Impact factor: 2.993

View more
  21 in total

Review 1.  Biomarkers for chronic fatigue.

Authors:  Nancy G Klimas; Gordon Broderick; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2012-06-23       Impact factor: 7.217

Review 2.  The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.

Authors:  Marco Filippi; Rainer Krähenmann; Patrick Fissler
Journal:  Front Psychol       Date:  2022-06-21

Review 3.  Long COVID-19 in Children: From the Pathogenesis to the Biologically Plausible Roots of the Syndrome.

Authors:  Michele Piazza; Maria Di Cicco; Luca Pecoraro; Michele Ghezzi; Diego Peroni; Pasquale Comberiati
Journal:  Biomolecules       Date:  2022-04-08

Review 4.  Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome.

Authors:  Gerwyn Morris; Michael Berk; Hans Klein; Ken Walder; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-06-23       Impact factor: 5.590

Review 5.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

Review 6.  Myalgic encephalomyelitis: International Consensus Criteria.

Authors:  B M Carruthers; M I van de Sande; K L De Meirleir; N G Klimas; G Broderick; T Mitchell; D Staines; A C P Powles; N Speight; R Vallings; L Bateman; B Baumgarten-Austrheim; D S Bell; N Carlo-Stella; J Chia; A Darragh; D Jo; D Lewis; A R Light; S Marshall-Gradisnik; I Mena; J A Mikovits; K Miwa; M Murovska; M L Pall; S Stevens
Journal:  J Intern Med       Date:  2011-08-22       Impact factor: 8.989

7.  Multivitamin mineral supplementation in patients with chronic fatigue syndrome.

Authors:  Daniela Maric; Snezana Brkic; Slavica Tomic; Aleksandra Novakov Mikic; Tatjana Cebovic; Vesna Turkulov
Journal:  Med Sci Monit       Date:  2014-01-14

Review 8.  A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.

Authors:  Gerwyn Morris; George Anderson; Piotr Galecki; Michael Berk; Michael Maes
Journal:  BMC Med       Date:  2013-03-08       Impact factor: 8.775

9.  Oxidative and Nitrosative Stress and Immune-Inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).

Authors:  Gerwyn Morris; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

Review 10.  Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics.

Authors:  Gerwyn Morris; Michael Maes
Journal:  BMC Med       Date:  2013-09-17       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.